Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Re: Comparative Analysis of Transperineal Template Saturation Prostate Biopsy Versus Magnetic Resonance Imaging Targeted Biopsy with Magnetic Resonance Imaging-Ultrasound Fusion Guidance.

Lazzeri M, Lughezzani G, Guazzoni G.

Eur Urol. 2015 Sep;68(3):535-6. doi: 10.1016/j.eururo.2015.05.025. No abstract available.

PMID:
26282352
2.

Two-dimensional neovascular complexity is significantly higher in nontumor prostate tissue than in low-risk prostate cancer.

Taverna G, Grizzi F, Colombo P, Seveso M, Giusti G, Proietti S, Fiorini G, Lughezzani G, Casale P, Buffi N, Lazzari M, Guazzoni G.

Korean J Urol. 2015 Jun;56(6):435-42. doi: 10.4111/kju.2015.56.6.435. Epub 2015 Jun 2.

3.

Preoperative prostate health index is an independent predictor of early biochemical recurrence after radical prostatectomy: Results from a prospective single-center study.

Lughezzani G, Lazzeri M, Buffi NM, Abrate A, Mistretta FA, Hurle R, Pasini L, Castaldo L, Zandegiacomo De Zorzi S, Peschechera R, Fiorini G, Taverna G, Casale P, Guazzoni G.

Urol Oncol. 2015 Aug;33(8):337.e7-337.e14. doi: 10.1016/j.urolonc.2015.05.007. Epub 2015 Jun 6.

PMID:
26055430
4.

Comparison of renal function detriments after local tumor ablation or partial nephrectomy for renal cell carcinoma.

Larcher A, Meskawi M, Valdivieso R, Boehm K, Trudeau V, Tian Z, Fossati N, Dell'Oglio P, Lughezzani G, Buffi N, Sun M, Karakiewicz P.

World J Urol. 2015 Jun 6. [Epub ahead of print]

PMID:
26047653
5.

Locally-advanced prostate cancer in the elderly: should we revisit our treatment paradigms?

Lughezzani G, Buffi NM.

Asian J Androl. 2015 Apr 28. doi: 10.4103/1008-682X.151394. [Epub ahead of print]

6.

Reply: To PMID 25733270.

Lista G, Lughezzani G, Buffi NM, Lazzeri M, Larcher A, Dell'Oglio P, Porter J, Ficarra V, Mottrie A, Guazzoni G.

Urology. 2015 Mar;85(3):595. doi: 10.1016/j.urology.2014.09.070. No abstract available.

PMID:
25733272
7.

Margin, ischemia, and complications system to report perioperative outcomes of robotic partial nephrectomy: a European Multicenter Observational Study (EMOS project).

Lista G, Buffi NM, Lughezzani G, Lazzeri M, Abrate A, Mistretta A, Larcher A, Dell'Oglio P, Fossati N, Porter J, Ficarra V, Mottrie A, Guazzoni G.

Urology. 2015 Mar;85(3):589-95. doi: 10.1016/j.urology.2014.09.068.

PMID:
25733270
8.

Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses.

Larcher A, Fossati N, Mistretta F, Lughezzani G, Lista G, Dell'Oglio P, Abrate A, Sun M, Karakiewicz P, Suardi N, Lazzeri M, Montorsi F, Guazzoni G, Buffi N.

Urol Oncol. 2015 Jan;33(1):22.e1-9. doi: 10.1016/j.urolonc.2014.09.003. Epub 2014 Oct 7.

PMID:
25301741
9.

Preoperative Prostate-specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer: Results from a Multicentric European Prospective Study.

Fossati N, Buffi NM, Haese A, Stephan C, Larcher A, McNicholas T, de la Taille A, Freschi M, Lughezzani G, Abrate A, Bini V, Palou Redorta J, Graefen M, Guazzoni G, Lazzeri M.

Eur Urol. 2015 Jul;68(1):132-8. doi: 10.1016/j.eururo.2014.07.034. Epub 2014 Aug 16.

PMID:
25139197
10.

Clinical performance of the Prostate Health Index (PHI) for the prediction of prostate cancer in obese men: data from the PROMEtheuS project, a multicentre European prospective study.

Abrate A, Lazzeri M, Lughezzani G, Buffi N, Bini V, Haese A, de la Taille A, McNicholas T, Redorta JP, Gadda GM, Lista G, Kinzikeeva E, Fossati N, Larcher A, Dell'Oglio P, Mistretta F, Freschi M, Guazzoni G.

BJU Int. 2015 Apr;115(4):537-45. doi: 10.1111/bju.12907.

PMID:
25130593
11.

Clinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literature.

Abrate A, Lughezzani G, Gadda GM, Lista G, Kinzikeeva E, Fossati N, Larcher A, Dell'Oglio P, Mistretta F, Buffi N, Guazzoni G, Lazzeri M.

Korean J Urol. 2014 Jul;55(7):436-45. doi: 10.4111/kju.2014.55.7.436. Epub 2014 Jul 11. Review.

12.

Bladder cancer and urothelial impairment: the role of TRPV1 as potential drug target.

Mistretta F, Buffi NM, Lughezzani G, Lista G, Larcher A, Fossati N, Abrate A, Dell'Oglio P, Montorsi F, Guazzoni G, Lazzeri M.

Biomed Res Int. 2014;2014:987149. doi: 10.1155/2014/987149. Epub 2014 May 8. Review.

13.

Robot-assisted, single-site, dismembered pyeloplasty for ureteropelvic junction obstruction with the new da Vinci platform: a stage 2a study.

Buffi NM, Lughezzani G, Fossati N, Lazzeri M, Guazzoni G, Lista G, Larcher A, Abrate A, Fiori C, Cestari A, Porpiglia F.

Eur Urol. 2015 Jan;67(1):151-6. doi: 10.1016/j.eururo.2014.03.001. Epub 2014 Mar 13.

PMID:
24656756
14.

Clinical performance of serum isoform [-2]proPSA (p2PSA), and its derivatives %p2PSA and the Prostate Health Index, in men aged <60 years: results from a multicentric European study.

Fossati N, Lazzeri M, Haese A, McNicholas T, de la Taille A, Buffi NM, Lughezzani G, Gadda GM, Lista G, Larcher A, Abrate A, Mistretta F, Bini V, Redorta JP, Graefen M, Guazzoni G.

BJU Int. 2015 Jun;115(6):913-20. doi: 10.1111/bju.12718. Epub 2015 Mar 26.

PMID:
24589357
15.

[Focal therapy and prostate cancer].

Lazzeri M, Losa A, Buffi N, Lughezzani G, Fossati N, Abrate A, Larcher A, Lista G, Mistretta A, Guazzoni G.

Urologia. 2013 Sep-Dec;80(4):283-9. doi: 10.5301/RU.2013.11667. Epub 2013 Dec 9. Review. Italian.

PMID:
24419922
16.

Prostatic metastases from testicular nonseminomatous germ cell cancer: two case reports and a review of the literature.

Torelli T, Lughezzani G, Catanzaro M, Nicolai N, Colecchia M, Biasoni D, Piva L, Maffezzini M, Stagni S, Necchi A, Giannatempo P, Farè E, Salvioni R.

Tumori. 2013 Sep-Oct;99(5):e203-7. doi: 10.1700/1377.15315. Review.

PMID:
24362870
17.

Multicenter European external validation of a prostate health index-based nomogram for predicting prostate cancer at extended biopsy.

Lughezzani G, Lazzeri M, Haese A, McNicholas T, de la Taille A, Buffi NM, Fossati N, Lista G, Larcher A, Abrate A, Mistretta A, Bini V, Palou Redorta J, Graefen M, Guazzoni G.

Eur Urol. 2014 Nov;66(5):906-12. doi: 10.1016/j.eururo.2013.12.005. Epub 2013 Dec 16.

PMID:
24361258
18.

Relationship of chronic histologic prostatic inflammation in biopsy specimens with serum isoform [-2]proPSA (p2PSA), %p2PSA, and prostate health index in men with a total prostate-specific antigen of 4-10 ng/ml and normal digital rectal examination.

Lazzeri M, Abrate A, Lughezzani G, Gadda GM, Freschi M, Mistretta F, Lista G, Fossati N, Larcher A, Kinzikeeva E, Buffi N, Dell'Acqua V, Bini V, Montorsi F, Guazzoni G.

Urology. 2014 Mar;83(3):606-12. doi: 10.1016/j.urology.2013.10.016. Epub 2013 Dec 6.

PMID:
24315305
19.

The relationship between characteristics of inguinal lymph nodes and pelvic lymph node involvement in penile squamous cell carcinoma: a single institution experience.

Lughezzani G, Catanzaro M, Torelli T, Piva L, Biasoni D, Stagni S, Crestani A, Guttilla A, Raggi D, Giannatempo P, Necchi A, Pizzocaro G, Colecchia M, Salvioni R, Nicolai N.

J Urol. 2014 Apr;191(4):977-82. doi: 10.1016/j.juro.2013.10.140. Epub 2013 Nov 18.

PMID:
24262497
20.

Relationship between lymph node ratio and cancer-specific survival in a contemporary series of patients with penile cancer and lymph node metastases.

Lughezzani G, Catanzaro M, Torelli T, Piva L, Biasoni D, Stagni S, Necchi A, Giannatempo P, Raggi D, Fare' E, Colecchia M, Pizzocaro G, Salvioni R, Nicolai N.

BJU Int. 2013 Oct 15. doi: 10.1111/bju.12510. [Epub ahead of print]

PMID:
24128128
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk